Skip to main content
Erschienen in: Virchows Archiv 2/2020

24.01.2020 | Original Article

The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature

verfasst von: Yuefang Sun, Ming Zhao, I Weng Lao, Lin Yu, Jian Wang

Erschienen in: Virchows Archiv | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

We present here our experience with 24 cases of pseudomyogenic hemangioendothelioma (PMHE) to further delineate its clinicopathological spectrum. There were 18 males and 6 females with a median age of 28 years (range 10~64 years). Most patients presented with erythematous nodules or papules, with or without pain. The majority (63%) occurred in the lower extremities, whereas a minority involved the trunk (25%), upper extremities (8%), and head and neck (4%). Six cases (25%) had a primary bone origin. With physical and radiological examinations, 16 cases (67%) manifested as multifocal disease, involving multiple tissue planes or different bones within the anatomic region. Six cases (25%) involved skin, soft tissue, and bone simultaneously. Histologically, all cases showed features consistent with a PMHE characterized by loose fascicles or sheets of plump spindled to epithelioid cells harboring brightly eosinophilic cytoplasm and vesicular nuclei. In addition, five cases (21%) contained a prominent myxoid matrix, and one case displayed perineural and intravascular invasion. The follow-up information available in 18 patients revealed local recurrence in 4 patients (22%) and persistent disease in 8 patients (44%), respectively. One patient developed bilateral pulmonary metastases which showed significant remission after systemic chemotherapy. None of the patients died of the disease. As the clinical appearance of PMHE can be deceptive, a radiological examination is essential in identifying an insidious multifocal disease. Although PMHE has a predilection for the distal extremities of young males, this rare tumor type could also occur in unusual sites and affect middle-aged adults of both genders. The striking myoid appearance in association with myxoid stromal change may represent a potential diagnostic pitfall. Biologically, PMHE has an indolent clinical behavior, albeit metastatic disease may occur in rare instance.
Literatur
1.
Zurück zum Zitat Hornick JL, Fletcher CD (2011) Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol 35:190–201PubMedCrossRef Hornick JL, Fletcher CD (2011) Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol 35:190–201PubMedCrossRef
2.
Zurück zum Zitat Billings SD, Folpe AL, Weiss SW (2003) Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 27:48–57PubMedCrossRef Billings SD, Folpe AL, Weiss SW (2003) Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 27:48–57PubMedCrossRef
3.
Zurück zum Zitat Amary MF, O'Donnell P, Berisha F, Tirabosco R, Briggs T, Pollock R, Flanagan AM (2013) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases. Skelet Radiol 42:947–957CrossRef Amary MF, O'Donnell P, Berisha F, Tirabosco R, Briggs T, Pollock R, Flanagan AM (2013) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases. Skelet Radiol 42:947–957CrossRef
4.
Zurück zum Zitat Righi A, Gambarotti M, Picci P, Dei Tos AP, Vanel D (2015) Primary pseudomyogenic haemangioendothelioma of bone: report of two cases. Skelet Radiol 44:727–731CrossRef Righi A, Gambarotti M, Picci P, Dei Tos AP, Vanel D (2015) Primary pseudomyogenic haemangioendothelioma of bone: report of two cases. Skelet Radiol 44:727–731CrossRef
5.
Zurück zum Zitat Pradhan D, Schoedel K, McGough RL, Ranganathan S, Rao UNM (2018) Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue—a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study. Hum Pathol 71:126–134PubMedCrossRef Pradhan D, Schoedel K, McGough RL, Ranganathan S, Rao UNM (2018) Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue—a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study. Hum Pathol 71:126–134PubMedCrossRef
6.
Zurück zum Zitat Sheng WQ, Wang J (2012) Primary pseudomyogenic haemangioendothelioma of bone. Histopathology 61:1219–1224PubMedCrossRef Sheng WQ, Wang J (2012) Primary pseudomyogenic haemangioendothelioma of bone. Histopathology 61:1219–1224PubMedCrossRef
7.
Zurück zum Zitat Sheng W, Pan Y, Wang J (2013) Pseudomyogenic hemangioendothelioma: report of an additional case with aggressive clinical course. Am J Dermatopathol 35:597–600PubMedCrossRef Sheng W, Pan Y, Wang J (2013) Pseudomyogenic hemangioendothelioma: report of an additional case with aggressive clinical course. Am J Dermatopathol 35:597–600PubMedCrossRef
9.
Zurück zum Zitat Mirra JM, Kessler S, Bhuta S, Eckardt J (1992) The fibroma-like variant of epithelioid sarcoma: a fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer 9:1382–1395 Mirra JM, Kessler S, Bhuta S, Eckardt J (1992) The fibroma-like variant of epithelioid sarcoma: a fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer 9:1382–1395
10.
Zurück zum Zitat Billings SD, Folpe AL, Weiss SW (2011) Epithelioid sarcoma-like hemangioendothelioma (pseudomyogenic hemangioendothelioma). Am J Surg Pathol 35:1088 author reply 1088-1089PubMedCrossRef Billings SD, Folpe AL, Weiss SW (2011) Epithelioid sarcoma-like hemangioendothelioma (pseudomyogenic hemangioendothelioma). Am J Surg Pathol 35:1088 author reply 1088-1089PubMedCrossRef
11.
Zurück zum Zitat Requena L, Santonja C, Martinez-Amo JL, Saus C, Kutzner H (2013) Cutaneous epithelioid sarcomalike (pseudomyogenic) hemangioendothelioma: a little-known low-grade cutaneous vascular neoplasm. JAMA Dermatol 149:459–465PubMedCrossRef Requena L, Santonja C, Martinez-Amo JL, Saus C, Kutzner H (2013) Cutaneous epithelioid sarcomalike (pseudomyogenic) hemangioendothelioma: a little-known low-grade cutaneous vascular neoplasm. JAMA Dermatol 149:459–465PubMedCrossRef
12.
Zurück zum Zitat McGinity BV, Dengler B, Birnbaum L, Henry J (2013) Pseudomyogenic hemangioendothelioma (epithelioid sarcoma-like hemangioendothelioma, fibroma-like variant of epithelioid sarcoma) of the thoracic spine. Eur Spine J 22(Suppl 3):S506–S511PubMedCrossRef McGinity BV, Dengler B, Birnbaum L, Henry J (2013) Pseudomyogenic hemangioendothelioma (epithelioid sarcoma-like hemangioendothelioma, fibroma-like variant of epithelioid sarcoma) of the thoracic spine. Eur Spine J 22(Suppl 3):S506–S511PubMedCrossRef
13.
Zurück zum Zitat Tsubokawa N, Harada H, Taniyama D, Uemura T, Kuraoka K, Yamashita Y (2016) Epithelioid sarcoma-like hemangioendothelioma on the chest wall. Asian Cardiovasc Thorac Ann 24(8):814–817PubMedCrossRef Tsubokawa N, Harada H, Taniyama D, Uemura T, Kuraoka K, Yamashita Y (2016) Epithelioid sarcoma-like hemangioendothelioma on the chest wall. Asian Cardiovasc Thorac Ann 24(8):814–817PubMedCrossRef
14.
Zurück zum Zitat Rawal YB, Anderson KM, Dodson TB (2017) Pseudomyogenic hemangioendothelioma: a vascular tumor previously undescribed in the oral cavity. Head Neck Pathol 11:525–530PubMedCrossRef Rawal YB, Anderson KM, Dodson TB (2017) Pseudomyogenic hemangioendothelioma: a vascular tumor previously undescribed in the oral cavity. Head Neck Pathol 11:525–530PubMedCrossRef
15.
Zurück zum Zitat Ge Y, Lin X, Zhang F, Xu F, Luo L, Huang W, Liu Z, Liu Y, Li Z (2019) A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature. Diagn Pathol 14(1):79PubMedPubMedCentralCrossRef Ge Y, Lin X, Zhang F, Xu F, Luo L, Huang W, Liu Z, Liu Y, Li Z (2019) A rare case of pseudomyogenic hemangioendothelioma (PHE)/epithelioid of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature. Diagn Pathol 14(1):79PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Ide YH, Tsukamoto Y, Ito T, Watanabe T, Nakagawa N, Haneda T, Nagai M, Yamanishi K, Hirota S (2015) Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR - report of a case. Pathol Res Pract 211:415–420PubMedCrossRef Ide YH, Tsukamoto Y, Ito T, Watanabe T, Nakagawa N, Haneda T, Nagai M, Yamanishi K, Hirota S (2015) Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR - report of a case. Pathol Res Pract 211:415–420PubMedCrossRef
17.
Zurück zum Zitat Raftopoulos E, Royer M, Warren M, Zhao J, Rush W (2018) Pseudomyogenic hemangioendothelioma: case report and review of the literature. Am J Dermatopathol 40(8):597–601PubMedCrossRef Raftopoulos E, Royer M, Warren M, Zhao J, Rush W (2018) Pseudomyogenic hemangioendothelioma: case report and review of the literature. Am J Dermatopathol 40(8):597–601PubMedCrossRef
18.
Zurück zum Zitat Fan C, Yang L, Lin X, Wang E (2015) Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case. Diagn Pathol 10:150PubMedPubMedCentralCrossRef Fan C, Yang L, Lin X, Wang E (2015) Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case. Diagn Pathol 10:150PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Dianat S, Yousaf H, Murugan P, Marette S (2019) Pseudomyogenic hemangioendothelioma—a case report and review of the literature. Radiol Case Rep 14(10):1228–1232PubMedPubMedCentralCrossRef Dianat S, Yousaf H, Murugan P, Marette S (2019) Pseudomyogenic hemangioendothelioma—a case report and review of the literature. Radiol Case Rep 14(10):1228–1232PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Kosemehmetoglu K, Rekhi B, Wakely PE Jr, Pant V, Dervisoglu S, Aydingoz U (2019) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma of bone: clinicopathologic features of 5 cases. Ann Diagn Pathol 41:116–123PubMedCrossRef Kosemehmetoglu K, Rekhi B, Wakely PE Jr, Pant V, Dervisoglu S, Aydingoz U (2019) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma of bone: clinicopathologic features of 5 cases. Ann Diagn Pathol 41:116–123PubMedCrossRef
21.
Zurück zum Zitat Inyang A, Mertens F, Puls F, Sumathi V, Inwards C, Folpe A, Lee CH, Zhang Y, Symmans P, Rubin B, Nielsen GP, Nguyen VH, Rosenberg AE (2016) Primary pseudomyogenic hemangioendothelioma of bone. Am J Surg Pathol 40:587–598PubMedCrossRef Inyang A, Mertens F, Puls F, Sumathi V, Inwards C, Folpe A, Lee CH, Zhang Y, Symmans P, Rubin B, Nielsen GP, Nguyen VH, Rosenberg AE (2016) Primary pseudomyogenic hemangioendothelioma of bone. Am J Surg Pathol 40:587–598PubMedCrossRef
22.
Zurück zum Zitat Bryanton M, Makis W (2015) Pseudomyogenic hemangioendothelioma mimicking multiple myeloma on 18F-FDG PET/CT, followed by spontaneous regression. Clin Nucl Med 40:579–581PubMedCrossRef Bryanton M, Makis W (2015) Pseudomyogenic hemangioendothelioma mimicking multiple myeloma on 18F-FDG PET/CT, followed by spontaneous regression. Clin Nucl Med 40:579–581PubMedCrossRef
23.
Zurück zum Zitat Ye C, Yu X, Zeng J, Liu H, Dai M (2016) Pseudomyogenic hemangioendothelioma secondary to fibrous dysplasia of the left lower extremity in a 14-year-old female: a case report. World J Surg Oncol 14(1):198PubMedPubMedCentralCrossRef Ye C, Yu X, Zeng J, Liu H, Dai M (2016) Pseudomyogenic hemangioendothelioma secondary to fibrous dysplasia of the left lower extremity in a 14-year-old female: a case report. World J Surg Oncol 14(1):198PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Cheo FF, Sittampalam K (2017) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma—a rare vascular neoplasm with deceptive morphology and distinctive immunophenotype. Malays J Pathol 39(3):305–309PubMed Cheo FF, Sittampalam K (2017) Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma—a rare vascular neoplasm with deceptive morphology and distinctive immunophenotype. Malays J Pathol 39(3):305–309PubMed
25.
Zurück zum Zitat Hung YP, Fletcher CDM, Hornick JL (2017) FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma. Am J Surg Pathol 41:596–606PubMedCrossRef Hung YP, Fletcher CDM, Hornick JL (2017) FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma. Am J Surg Pathol 41:596–606PubMedCrossRef
26.
Zurück zum Zitat Sugita S, Hirano H, Kikuchi N, Kubo T, Asanuma H, Aoyama T, Emori M, Hasegawa T (2016) Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics. Diagn Pathol 11(1):75PubMedPubMedCentralCrossRef Sugita S, Hirano H, Kikuchi N, Kubo T, Asanuma H, Aoyama T, Emori M, Hasegawa T (2016) Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics. Diagn Pathol 11(1):75PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Ortins-Pina A, Llamas-Velasco M, Turpin S, Soares-de-Almeida L, Filipe P, Kutzner H (2018) FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia). J Cutan Pathol 45(6):395–402PubMedCrossRef Ortins-Pina A, Llamas-Velasco M, Turpin S, Soares-de-Almeida L, Filipe P, Kutzner H (2018) FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia). J Cutan Pathol 45(6):395–402PubMedCrossRef
28.
Zurück zum Zitat Fittall MW, Mifsud W, Pillay N, Ye H, Strobl AC, Verfaillie A, Demeulemeester J, Zhang L, Berisha F, Tarabichi M, Young MD, Miranda E, Tarpey PS, Tirabosco R, Amary F, Grigoriadis AE, Stratton MR, Van Loo P, Antonescu CR, Campbell PJ, Flanagan AM, Behjati S (2018) Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nat Commun 9(1):2150PubMedPubMedCentralCrossRef Fittall MW, Mifsud W, Pillay N, Ye H, Strobl AC, Verfaillie A, Demeulemeester J, Zhang L, Berisha F, Tarabichi M, Young MD, Miranda E, Tarpey PS, Tirabosco R, Amary F, Grigoriadis AE, Stratton MR, Van Loo P, Antonescu CR, Campbell PJ, Flanagan AM, Behjati S (2018) Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nat Commun 9(1):2150PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Amary F, Markert E, Berisha F, Ye H, Gerrand C, Cool P, Tirabosco R, Lindsay D, Pillay N, O'Donnell P, Baumhoer D, Flanagan AM (2019) FOS expression in osteoid osteoma and osteoblastoma: a valuable ancillary diagnostic tool. Am J Surg Pathol 43:1661–1667PubMedCrossRef Amary F, Markert E, Berisha F, Ye H, Gerrand C, Cool P, Tirabosco R, Lindsay D, Pillay N, O'Donnell P, Baumhoer D, Flanagan AM (2019) FOS expression in osteoid osteoma and osteoblastoma: a valuable ancillary diagnostic tool. Am J Surg Pathol 43:1661–1667PubMedCrossRef
31.
Zurück zum Zitat Trombetta D, Magnusson L, von Steyern FV, Hornick JL, Fletcher CD, Mertens F (2011) Translocation t(7;19)(q22;q13)—a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma? Cancer Gene Ther 204:211–215CrossRef Trombetta D, Magnusson L, von Steyern FV, Hornick JL, Fletcher CD, Mertens F (2011) Translocation t(7;19)(q22;q13)—a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma? Cancer Gene Ther 204:211–215CrossRef
32.
Zurück zum Zitat Walther C, Tayebwa J, Lilljebjörn H, Magnusson L, Nilsson J, von Steyern FV, Øra I, Domanski HA, Fioretos T, Nord KH, Fletcher CD, Mertens F (2014) A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol 232:534–540PubMedCrossRef Walther C, Tayebwa J, Lilljebjörn H, Magnusson L, Nilsson J, von Steyern FV, Øra I, Domanski HA, Fioretos T, Nord KH, Fletcher CD, Mertens F (2014) A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma. J Pathol 232:534–540PubMedCrossRef
33.
Zurück zum Zitat Agaram NP, Zhang L, Cotzia P, Antonescu CR (2018) Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions. Am J Surg Pathol 42:1653–1661PubMedPubMedCentralCrossRef Agaram NP, Zhang L, Cotzia P, Antonescu CR (2018) Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions. Am J Surg Pathol 42:1653–1661PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Panagopoulos I, Lobmaier I, Gorunova L, Heim S (2019) Fusion of the genes WWTR1 and FOSB in pseudomyogenic hemangioendothelioma. Cancer Genomics Proteomics 16:293–298PubMedPubMedCentralCrossRef Panagopoulos I, Lobmaier I, Gorunova L, Heim S (2019) Fusion of the genes WWTR1 and FOSB in pseudomyogenic hemangioendothelioma. Cancer Genomics Proteomics 16:293–298PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Milde-Langosch K (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 41:2449–2461 Milde-Langosch K (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer 41:2449–2461
36.
Zurück zum Zitat Danforth OM, Tamulonis K, Vavra K, Oh C, Brickman A, Ebersole J, Cameron J, Mahon B, Kent P (2019) Effective use of sirolimus and zoledronic acid for multiosteotic pseudomyogenic hemangioendothelioma of the bone in a child: case report and review of literature. J Pediatr Hematol Oncol 41(5):382–387PubMedCrossRef Danforth OM, Tamulonis K, Vavra K, Oh C, Brickman A, Ebersole J, Cameron J, Mahon B, Kent P (2019) Effective use of sirolimus and zoledronic acid for multiosteotic pseudomyogenic hemangioendothelioma of the bone in a child: case report and review of literature. J Pediatr Hematol Oncol 41(5):382–387PubMedCrossRef
37.
Zurück zum Zitat van IJzendoorn DGP, Sleijfer S, Gelderblom H, Eskens FALM, van Leenders GJLH, Szuhai K, Bovée JVMG (2018) Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma. Clin Cancer Res 24:2678–2687PubMedCrossRef van IJzendoorn DGP, Sleijfer S, Gelderblom H, Eskens FALM, van Leenders GJLH, Szuhai K, Bovée JVMG (2018) Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma. Clin Cancer Res 24:2678–2687PubMedCrossRef
38.
Zurück zum Zitat Gabor KM, Sapi Z, Tiszlavicz LG, Fige A, Bereczki C, Bartyik K (2018) Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma. Pediatr Blood Cancer 65:4–7CrossRef Gabor KM, Sapi Z, Tiszlavicz LG, Fige A, Bereczki C, Bartyik K (2018) Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma. Pediatr Blood Cancer 65:4–7CrossRef
39.
Zurück zum Zitat Ozeki M, Nozawa A, Kanda K, Hori T, Nagano A, Shimada A, Miyazaki T, Fukao T (2017) Everolimus for treatment of pseudomyogenic hemangioendothelioma. J Pediatr Hematol Oncol 39(6):e328PubMedCrossRef Ozeki M, Nozawa A, Kanda K, Hori T, Nagano A, Shimada A, Miyazaki T, Fukao T (2017) Everolimus for treatment of pseudomyogenic hemangioendothelioma. J Pediatr Hematol Oncol 39(6):e328PubMedCrossRef
40.
Zurück zum Zitat Otani S, Nakayama R, Sekita T, Hirozane T, Asano N, Nishimoto K, Sasaki A, Okita H, Morioka H, Nakamura M, Matsumoto M (2019) Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report. BMC Cancer 19:872PubMedPubMedCentralCrossRef Otani S, Nakayama R, Sekita T, Hirozane T, Asano N, Nishimoto K, Sasaki A, Okita H, Morioka H, Nakamura M, Matsumoto M (2019) Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report. BMC Cancer 19:872PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Horan NA, DiMaio DJ (2017) Pseudomyogenic hemangioendothelioma. Cutis 100:E13–E16PubMed Horan NA, DiMaio DJ (2017) Pseudomyogenic hemangioendothelioma. Cutis 100:E13–E16PubMed
42.
Zurück zum Zitat Shah AR, Fernando M, Musson R, Kotnis N (2015) An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature. Skelet Radiol 44:1381–1386CrossRef Shah AR, Fernando M, Musson R, Kotnis N (2015) An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature. Skelet Radiol 44:1381–1386CrossRef
Metadaten
Titel
The clinicopathological spectrum of pseudomyogenic hemangioendothelioma: report of an additional series with review of the literature
verfasst von
Yuefang Sun
Ming Zhao
I Weng Lao
Lin Yu
Jian Wang
Publikationsdatum
24.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 2/2020
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-020-02753-4

Weitere Artikel der Ausgabe 2/2020

Virchows Archiv 2/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie